# A Study of the Efficacy and Safety of Brensocatib in Participants With Chronic Rhinosinusitis Without Nasal Polyps (CRSsNP)

> **NCT06013241** · PHASE2 · COMPLETED · sponsor: **Insmed Incorporated** · enrollment: 288 (actual)

## Conditions studied

- Chronic Rhinosinusitis Without Nasal Polyps

## Interventions

- **DRUG:** Brensocatib
- **DRUG:** Placebo
- **DRUG:** Mometasone furoate nasal spray (MFNS)

## Key facts

- **NCT ID:** NCT06013241
- **Lead sponsor:** Insmed Incorporated
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-10-30
- **Primary completion:** 2025-09-30
- **Final completion:** 2025-10-30
- **Target enrollment:** 288 (ACTUAL)
- **Last updated:** 2025-11-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06013241

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06013241, "A Study of the Efficacy and Safety of Brensocatib in Participants With Chronic Rhinosinusitis Without Nasal Polyps (CRSsNP)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06013241. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*